International Women’s Day: “Everyone benefits from raising awareness”
Women and Parkinson's
Author: Sarah McGrathPublished: 3 March 2022
Prep: Cook: Serves:
Around three million women worldwide are living with Parkinson’s – but their specific needs and experiences are often neglected. Ahead of International Women’s Day 2022, we look back at our #WomenandParkinsons campaign – where interviewees share how the condition has impacted their lives
We launched the #WomenAndParkinsons campaign in 2019 to highlight the knowledge gap around how Parkinson’s affects women. Investigating the topic revealed some shocking insights. Women experience a more rapid disease progression, a lower survival rate, are less likely to be monitored by a movement disorders specialist – and are less likely than men to undergo complex treatments like deep brain stimulation.
At the start of the campaign, Russell Patten, director general of the European Parkinson’s Disease Association (EPDA), said: “This campaign is necessary if women living with Parkinson’s are to receive what they, and everyone living with Parkinson’s, deserve: an appropriate diagnosis, improved treatment options and a better quality of life.”
More than two years later, we’ve been lucky to speak to women in the community about a variety of subjects including diagnosis, menopause, medication and research.
Ireland-based dietician Richelle Flanagan hid her Parkinson’s diagnosis for two years, for “fear of judgment”. But after meeting other people with the condition and visiting the World Parkinson Congress in 2019, she felt motivated to share her story.
Making people aware of the impact the condition has on women was particularly important to Richelle. So far she has set up a survey about hormones and women’s Parkinson’s symptoms, and co-founded the Women’s Parkinson’s Project to help advocate for better treatment and research for women living with the condition. After all, Richelle says, “everyone benefits from raising awareness”.
Series one of the Parkinson’s Life podcast saw campaigners Sharon Krischer, Omotola Thomas and Mariette Robijn get together, discussing topics that ranged from the stereotype that people with Parkinson’s tend to be “old, grey, dusty men”, to the discovery that symptoms “will be worse during your period”. The group noted that being better informed about Parkinson’s during their diagnosis “would have made a difference” to their experiences of the condition.
When Cathy Molohan was first diagnosed with Parkinson’s, she was “determined” not to let the condition stop her role co-running the communications company EnglishBusiness.
Although Parkinson’s symptoms meant parts of the work became “exhausting”, Cathy was grateful to her “amazing” colleagues and clients for their support. “It was a hard balancing act to look after myself and my business commitments at the same time,” she explains.
Cathy eventually decided to leave her job to focus on spending time with her family. “It’s essential to create a workplace where chronic illness is not a taboo,” she says. “I think many women try and be everything and do everything – Parkinson’s just doesn’t allow that. Or at least, it forces you to choose what and how much you do.”
At the age of 37, a Parkinson’s diagnosis left Teresa Borque with a “monumental” identity crisis. She initially struggled, as she left her job as a journalist and grappled with impulsive behaviours linked to her Parkinson’s medication. But after having psychological therapy at a specialised centre for women, Teresa began to accept the condition and put her life in place.
“Women have to learn to be their own highest priority in life,” she says. “We have to learn to say ‘me first’, we have to learn to say ‘no’ on our own, without the consent of the group. We have to learn to be impervious to social judgment – even more so if health is at stake.”
Women “have to learn to be their own highest priority”, says Teresa Borque.
Women and Parkinson’s: Our campaign
It is estimated that three million women worldwide are living with Parkinson’s – yet their specific needs and experiences are often ignored, leading to disparities in diagnosis, treatment and medication. Our campaign shares the little-heard stories of women with the condition to find out how their lives are being affected by a shocking data gap when it comes to women and Parkinson’s. This is just the start.
We want to raise awareness of women’s experience of the condition within the medical profession, so that women’s symptoms are taken seriously.
We think more research is needed into the impact of Parkinson’s on women, so that they can benefit from tailored medication and treatment.
We want to explore ways to offer better support for those women managing the condition alongside caring responsibilities.
#WomenAndParkinsons shortlisted for ‘Charity Content Campaign of the Year’
Parkinson’s Life’s #WomenAndParkinsons campaign – a series highlighti
7 days ago
Is there a link between Parkinson’s disease and blood vessel dysfunction?
Scientists in Slovakia have investigated the link between blood vessel dysfunction and Parkinson’s – and found that dopamine agonists may have an impact. The team studied the function of the endothelium – a membrane which lines the heart and blood vessels and helps control blood fluidity – in 41 people with the condition and 41 people without. Endothelial function was then measured through a parameter that assessed how easily blood could flow through the vessels. The results showed that while more people with Parkinson’s had endothelial dysfunction compared to those without, the difference did not reach statistical significance. However, the researchers noted that the findings suggested “an association between smoking, dopamine agonists, and impaired endothelial function” in those with the condition. Outlining the study’s limitations, the team noted that more research is needed to explore this potential link.
New swab test may help with Parkinson’s disease diagnosis
Researchers at the University of Manchester, UK, have drawn on one woman’s sense of smell to develop a swab test that may be used to detect Parkinson’s. The scientists used the test to analyse sebum (a type of oily substance on the skin) in 79 people with Parkinson’s and a control group of 71 healthy individuals. The team identified more than 4,000 different compounds in the participant samples – including 500 that were unique to those living with the condition. The test was developed with the help of Joy Milne from Perth, Scotland, whose unique sense of smell meant that she noticed a change in her late husband Les’s odour twelve years before he was diagnosed with Parkinson’s. Speaking to the BBC, Professor Perdita Barran, who led the research, described the test as potentially “transformative” – and said that the team hopes to roll the test out to people in…
Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?
A biobank is a collection of biological samples and data designed to be used for research. Now, researchers in Australia are working to build a biobank for Parkinson’s. As part of the project, the scientists are conducting scans of people that have been injected with fluorodopa – a substance that highlights dopamine in the brain. Participants include people living with Parkinson’s and a control group of people without the condition. The resulting database of scans will be used to create a national biobank that aims to inform treatment and research into the condition. Commenting on the study, Olivia Nasser – executive director at the Hospital Research Foundation, which is helping to fund the research – said, “Once we build up the biobank of scans, it can actually be used as an effective way to treat Parkinson’s.” The researchers encourage people with and without Parkinson’s to take part in the trial.